Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 06, 2025 16:45 ET | Source: Neuronetics MALVERN, Pa., Aug. 06,…
Gilat Reports Second Quarter 2025 Results
Revenues Increased by 37%; GAAP Operating Income of $5.7 Million; Adjusted EBITDA…
Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update
Recorded second quarter 2025 worldwide revenue of $378.0 million, GAAP fully diluted…
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 16:15 ET | Source: ImageneBio, Inc. SAN DIEGO, Aug.…
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 16:08 ET | Source: Protara Therapeutics NEW YORK, Aug.…
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 16:05 ET | Source: Akebia Therapeutics, Inc. CAMBRIDGE, Mass.,…
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 16:55 ET | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British…
Pacific Health Care Organization, Inc. Reports its Second Quarter 2025 Financial Results
Irvine, July 31, 2025 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc.,…
e& reports 60.7% increase in consolidated net profit, reaching AED 8.8 billion in H1 2025
Q2 consolidated revenue increased to AED 18.0 billion, a 28.1% year-on-year growthQ2 consolidated…
Star Health Insurance Reports Strong Performance Q1FY26 PAT Grows 44% to INR 438 Cr (IFRS), Premium Grows 13%
Combined ratio on an IFRS basis was 99.6% for Q1FY26Retail GWP grew…
